1 Human VEGF Antibody Market Overview 1.1 Product Overview and Scope of Human VEGF Antibody 1.2 Human VEGF Antibody Segment by Type 1.2.1 Global Human VEGF Antibody Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Rabbit 1.2.3 Mouse 1.2.4 Goat 1.2.5 Others 1.3 Human VEGF Antibody Segment by Application 1.3.1 Global Human VEGF Antibody Sales Comparison by Application: (2022-2028) 1.3.2 Laboratory 1.3.3 Hospital 1.3.4 Others 1.4 Global Human VEGF Antibody Market Size Estimates and Forecasts 1.4.1 Global Human VEGF Antibody Revenue 2017-2028 1.4.2 Global Human VEGF Antibody Sales 2017-2028 1.4.3 Human VEGF Antibody Market Size by Region: 2017 Versus 2021 Versus 2028 2 Human VEGF Antibody Market Competition by Manufacturers 2.1 Global Human VEGF Antibody Sales Market Share by Manufacturers (2017-2022) 2.2 Global Human VEGF Antibody Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Human VEGF Antibody Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Human VEGF Antibody Manufacturing Sites, Area Served, Product Type 2.5 Human VEGF Antibody Market Competitive Situation and Trends 2.5.1 Human VEGF Antibody Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Human VEGF Antibody Players Market Share by Revenue 2.5.3 Global Human VEGF Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Human VEGF Antibody Retrospective Market Scenario by Region 3.1 Global Human VEGF Antibody Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Human VEGF Antibody Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Human VEGF Antibody Market Facts & Figures by Country 3.3.1 North America Human VEGF Antibody Sales by Country 3.3.2 North America Human VEGF Antibody Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Human VEGF Antibody Market Facts & Figures by Country 3.4.1 Europe Human VEGF Antibody Sales by Country 3.4.2 Europe Human VEGF Antibody Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Human VEGF Antibody Market Facts & Figures by Region 3.5.1 Asia Pacific Human VEGF Antibody Sales by Region 3.5.2 Asia Pacific Human VEGF Antibody Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Human VEGF Antibody Market Facts & Figures by Country 3.6.1 Latin America Human VEGF Antibody Sales by Country 3.6.2 Latin America Human VEGF Antibody Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Human VEGF Antibody Market Facts & Figures by Country 3.7.1 Middle East and Africa Human VEGF Antibody Sales by Country 3.7.2 Middle East and Africa Human VEGF Antibody Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Human VEGF Antibody Historic Market Analysis by Type 4.1 Global Human VEGF Antibody Sales Market Share by Type (2017-2022) 4.2 Global Human VEGF Antibody Revenue Market Share by Type (2017-2022) 4.3 Global Human VEGF Antibody Price by Type (2017-2022) 5 Global Human VEGF Antibody Historic Market Analysis by Application 5.1 Global Human VEGF Antibody Sales Market Share by Application (2017-2022) 5.2 Global Human VEGF Antibody Revenue Market Share by Application (2017-2022) 5.3 Global Human VEGF Antibody Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Thermo Fisher 6.1.1 Thermo Fisher Corporation Information 6.1.2 Thermo Fisher Description and Business Overview 6.1.3 Thermo Fisher Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Thermo Fisher Human VEGF Antibody Product Portfolio 6.1.5 Thermo Fisher Recent Developments/Updates 6.2 MilliporeSigma 6.2.1 MilliporeSigma Corporation Information 6.2.2 MilliporeSigma Description and Business Overview 6.2.3 MilliporeSigma Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.2.4 MilliporeSigma Human VEGF Antibody Product Portfolio 6.2.5 MilliporeSigma Recent Developments/Updates 6.3 Santa Cruz Biotechnology 6.3.1 Santa Cruz Biotechnology Corporation Information 6.3.2 Santa Cruz Biotechnology Description and Business Overview 6.3.3 Santa Cruz Biotechnology Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Santa Cruz Biotechnology Human VEGF Antibody Product Portfolio 6.3.5 Santa Cruz Biotechnology Recent Developments/Updates 6.4 Abcam 6.4.1 Abcam Corporation Information 6.4.2 Abcam Description and Business Overview 6.4.3 Abcam Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Abcam Human VEGF Antibody Product Portfolio 6.4.5 Abcam Recent Developments/Updates 6.5 R&D Systems 6.5.1 R&D Systems Corporation Information 6.5.2 R&D Systems Description and Business Overview 6.5.3 R&D Systems Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.5.4 R&D Systems Human VEGF Antibody Product Portfolio 6.5.5 R&D Systems Recent Developments/Updates 6.6 Novus Biologicals 6.6.1 Novus Biologicals Corporation Information 6.6.2 Novus Biologicals Description and Business Overview 6.6.3 Novus Biologicals Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Novus Biologicals Human VEGF Antibody Product Portfolio 6.6.5 Novus Biologicals Recent Developments/Updates 6.7 Abnova 6.6.1 Abnova Corporation Information 6.6.2 Abnova Description and Business Overview 6.6.3 Abnova Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Abnova Human VEGF Antibody Product Portfolio 6.7.5 Abnova Recent Developments/Updates 6.8 ImmunoStar 6.8.1 ImmunoStar Corporation Information 6.8.2 ImmunoStar Description and Business Overview 6.8.3 ImmunoStar Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.8.4 ImmunoStar Human VEGF Antibody Product Portfolio 6.8.5 ImmunoStar Recent Developments/Updates 6.9 OriGene 6.9.1 OriGene Corporation Information 6.9.2 OriGene Description and Business Overview 6.9.3 OriGene Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.9.4 OriGene Human VEGF Antibody Product Portfolio 6.9.5 OriGene Recent Developments/Updates 6.10 LifeSpan Biosciences 6.10.1 LifeSpan Biosciences Corporation Information 6.10.2 LifeSpan Biosciences Description and Business Overview 6.10.3 LifeSpan Biosciences Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.10.4 LifeSpan Biosciences Human VEGF Antibody Product Portfolio 6.10.5 LifeSpan Biosciences Recent Developments/Updates 6.11 Sino Biological 6.11.1 Sino Biological Corporation Information 6.11.2 Sino Biological Human VEGF Antibody Description and Business Overview 6.11.3 Sino Biological Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Sino Biological Human VEGF Antibody Product Portfolio 6.11.5 Sino Biological Recent Developments/Updates 6.12 Bio-Rad 6.12.1 Bio-Rad Corporation Information 6.12.2 Bio-Rad Human VEGF Antibody Description and Business Overview 6.12.3 Bio-Rad Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Bio-Rad Human VEGF Antibody Product Portfolio 6.12.5 Bio-Rad Recent Developments/Updates 6.13 BioLegend 6.13.1 BioLegend Corporation Information 6.13.2 BioLegend Human VEGF Antibody Description and Business Overview 6.13.3 BioLegend Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.13.4 BioLegend Human VEGF Antibody Product Portfolio 6.13.5 BioLegend Recent Developments/Updates 6.14 Rockland Immunochemicals 6.14.1 Rockland Immunochemicals Corporation Information 6.14.2 Rockland Immunochemicals Human VEGF Antibody Description and Business Overview 6.14.3 Rockland Immunochemicals Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.14.4 Rockland Immunochemicals Human VEGF Antibody Product Portfolio 6.14.5 Rockland Immunochemicals Recent Developments/Updates 6.15 Agrisera 6.15.1 Agrisera Corporation Information 6.15.2 Agrisera Human VEGF Antibody Description and Business Overview 6.15.3 Agrisera Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.15.4 Agrisera Human VEGF Antibody Product Portfolio 6.15.5 Agrisera Recent Developments/Updates 6.16 Boster 6.16.1 Boster Corporation Information 6.16.2 Boster Human VEGF Antibody Description and Business Overview 6.16.3 Boster Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.16.4 Boster Human VEGF Antibody Product Portfolio 6.16.5 Boster Recent Developments/Updates 6.17 ProMab 6.17.1 ProMab Corporation Information 6.17.2 ProMab Human VEGF Antibody Description and Business Overview 6.17.3 ProMab Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.17.4 ProMab Human VEGF Antibody Product Portfolio 6.17.5 ProMab Recent Developments/Updates 6.18 Creative Biomart 6.18.1 Creative Biomart Corporation Information 6.18.2 Creative Biomart Human VEGF Antibody Description and Business Overview 6.18.3 Creative Biomart Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.18.4 Creative Biomart Human VEGF Antibody Product Portfolio 6.18.5 Creative Biomart Recent Developments/Updates 6.19 Enzo Life Sciences 6.19.1 Enzo Life Sciences Corporation Information 6.19.2 Enzo Life Sciences Human VEGF Antibody Description and Business Overview 6.19.3 Enzo Life Sciences Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.19.4 Enzo Life Sciences Human VEGF Antibody Product Portfolio 6.19.5 Enzo Life Sciences Recent Developments/Updates 6.20 Bon Opus Biosciences 6.20.1 Bon Opus Biosciences Corporation Information 6.20.2 Bon Opus Biosciences Human VEGF Antibody Description and Business Overview 6.20.3 Bon Opus Biosciences Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.20.4 Bon Opus Biosciences Human VEGF Antibody Product Portfolio 6.20.5 Bon Opus Biosciences Recent Developments/Updates 6.21 Absolute Antibody 6.21.1 Absolute Antibody Corporation Information 6.21.2 Absolute Antibody Human VEGF Antibody Description and Business Overview 6.21.3 Absolute Antibody Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.21.4 Absolute Antibody Human VEGF Antibody Product Portfolio 6.21.5 Absolute Antibody Recent Developments/Updates 6.22 US Biological 6.22.1 US Biological Corporation Information 6.22.2 US Biological Human VEGF Antibody Description and Business Overview 6.22.3 US Biological Human VEGF Antibody Sales, Revenue and Gross Margin (2017-2022) 6.22.4 US Biological Human VEGF Antibody Product Portfolio 6.22.5 US Biological Recent Developments/Updates 7 Human VEGF Antibody Manufacturing Cost Analysis 7.1 Human VEGF Antibody Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Human VEGF Antibody 7.4 Human VEGF Antibody Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Human VEGF Antibody Distributors List 8.3 Human VEGF Antibody Customers 9 Human VEGF Antibody Market Dynamics 9.1 Human VEGF Antibody Industry Trends 9.2 Human VEGF Antibody Market Drivers 9.3 Human VEGF Antibody Market Challenges 9.4 Human VEGF Antibody Market Restraints 10 Global Market Forecast 10.1 Human VEGF Antibody Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Human VEGF Antibody by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Human VEGF Antibody by Type (2023-2028) 10.2 Human VEGF Antibody Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Human VEGF Antibody by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Human VEGF Antibody by Application (2023-2028) 10.3 Human VEGF Antibody Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Human VEGF Antibody by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Human VEGF Antibody by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Human VEGF Antibody Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million) Table 2. Global Human VEGF Antibody Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million) Table 3. Global Human VEGF Antibody Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Human VEGF Antibody Market Competitive Situation by Manufacturers in 2021 Table 5. Global Human VEGF Antibody Sales (Kg) of Key Manufacturers (2017-2022) Table 6. Global Human VEGF Antibody Sales Market Share by Manufacturers (2017-2022) Table 7. Global Human VEGF Antibody Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Human VEGF Antibody Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Human VEGF Antibody Average Price (USD/g) of Key Manufacturers (2017-2022) Table 10. Manufacturers Human VEGF Antibody Manufacturing Sites and Area Served Table 11. Manufacturers Human VEGF Antibody Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Human VEGF Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human VEGF Antibody as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Human VEGF Antibody Sales by Region (2017-2022) & (Kg) Table 16. Global Human VEGF Antibody Sales Market Share by Region (2017-2022) Table 17. Global Human VEGF Antibody Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Human VEGF Antibody Revenue Market Share by Region (2017-2022) Table 19. North America Human VEGF Antibody Sales by Country (2017-2022) & (Kg) Table 20. North America Human VEGF Antibody Sales Market Share by Country (2017-2022) Table 21. North America Human VEGF Antibody Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Human VEGF Antibody Revenue Market Share by Country (2017-2022) Table 23. Europe Human VEGF Antibody Sales by Country (2017-2022) & (Kg) Table 24. Europe Human VEGF Antibody Sales Market Share by Country (2017-2022) Table 25. Europe Human VEGF Antibody Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Human VEGF Antibody Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Human VEGF Antibody Sales by Region (2017-2022) & (Kg) Table 28. Asia Pacific Human VEGF Antibody Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Human VEGF Antibody Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Human VEGF Antibody Revenue Market Share by Region (2017-2022) Table 31. Latin America Human VEGF Antibody Sales by Country (2017-2022) & (Kg) Table 32. Latin America Human VEGF Antibody Sales Market Share by Country (2017-2022) Table 33. Latin America Human VEGF Antibody Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Human VEGF Antibody Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Human VEGF Antibody Sales by Country (2017-2022) & (Kg) Table 36. Middle East and Africa Human VEGF Antibody Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Human VEGF Antibody Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Human VEGF Antibody Revenue Market Share by Country (2017-2022) Table 39. Global Human VEGF Antibody Sales by Type (2017-2022) & (Kg) Table 40. Global Human VEGF Antibody Sales Market Share by Type (2017-2022) Table 41. Global Human VEGF Antibody Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Human VEGF Antibody Revenue Share by Type (2017-2022) Table 43. Global Human VEGF Antibody Price by Type (2017-2022) & (USD/g) Table 44. Global Human VEGF Antibody Sales (Kg) by Application (2017-2022) Table 45. Global Human VEGF Antibody Sales Market Share by Application (2017-2022) Table 46. Global Human VEGF Antibody Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Human VEGF Antibody Revenue Share by Application (2017-2022) Table 48. Global Human VEGF Antibody Price by Application (2017-2022) & (USD/g) Table 49. Thermo Fisher Corporation Information Table 50. Thermo Fisher Description and Business Overview Table 51. Thermo Fisher Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 52. Thermo Fisher Human VEGF Antibody Product Table 53. Thermo Fisher Recent Developments/Updates Table 54. MilliporeSigma Corporation Information Table 55. MilliporeSigma Description and Business Overview Table 56. MilliporeSigma Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 57. MilliporeSigma Human VEGF Antibody Product Table 58. MilliporeSigma Recent Developments/Updates Table 59. Santa Cruz Biotechnology Corporation Information Table 60. Santa Cruz Biotechnology Description and Business Overview Table 61. Santa Cruz Biotechnology Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 62. Santa Cruz Biotechnology Human VEGF Antibody Product Table 63. Santa Cruz Biotechnology Recent Developments/Updates Table 64. Abcam Corporation Information Table 65. Abcam Description and Business Overview Table 66. Abcam Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 67. Abcam Human VEGF Antibody Product Table 68. Abcam Recent Developments/Updates Table 69. R&D Systems Corporation Information Table 70. R&D Systems Description and Business Overview Table 71. R&D Systems Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 72. R&D Systems Human VEGF Antibody Product Table 73. R&D Systems Recent Developments/Updates Table 74. Novus Biologicals Corporation Information Table 75. Novus Biologicals Description and Business Overview Table 76. Novus Biologicals Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 77. Novus Biologicals Human VEGF Antibody Product Table 78. Novus Biologicals Recent Developments/Updates Table 79. Abnova Corporation Information Table 80. Abnova Description and Business Overview Table 81. Abnova Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 82. Abnova Human VEGF Antibody Product Table 83. Abnova Recent Developments/Updates Table 84. ImmunoStar Corporation Information Table 85. ImmunoStar Description and Business Overview Table 86. ImmunoStar Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 87. ImmunoStar Human VEGF Antibody Product Table 88. ImmunoStar Recent Developments/Updates Table 89. OriGene Corporation Information Table 90. OriGene Description and Business Overview Table 91. OriGene Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 92. OriGene Human VEGF Antibody Product Table 93. OriGene Recent Developments/Updates Table 94. LifeSpan Biosciences Corporation Information Table 95. LifeSpan Biosciences Description and Business Overview Table 96. LifeSpan Biosciences Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 97. LifeSpan Biosciences Human VEGF Antibody Product Table 98. LifeSpan Biosciences Recent Developments/Updates Table 99. Sino Biological Corporation Information Table 100. Sino Biological Description and Business Overview Table 101. Sino Biological Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 102. Sino Biological Human VEGF Antibody Product Table 103. Sino Biological Recent Developments/Updates Table 104. Bio-Rad Corporation Information Table 105. Bio-Rad Description and Business Overview Table 106. Bio-Rad Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 107. Bio-Rad Human VEGF Antibody Product Table 108. Bio-Rad Recent Developments/Updates Table 109. BioLegend Corporation Information Table 110. BioLegend Description and Business Overview Table 111. BioLegend Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 112. BioLegend Human VEGF Antibody Product Table 113. BioLegend Recent Developments/Updates Table 114. Rockland Immunochemicals Corporation Information Table 115. Rockland Immunochemicals Description and Business Overview Table 116. Rockland Immunochemicals Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 117. Rockland Immunochemicals Human VEGF Antibody Product Table 118. Rockland Immunochemicals Recent Developments/Updates Table 119. Agrisera Corporation Information Table 120. Agrisera Description and Business Overview Table 121. Agrisera Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 122. Agrisera Human VEGF Antibody Product Table 123. Agrisera Recent Developments/Updates Table 124. Boster Corporation Information Table 125. Boster Description and Business Overview Table 126. Boster Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 127. Boster Human VEGF Antibody Product Table 128. Boster Recent Developments/Updates Table 129. ProMab Corporation Information Table 130. ProMab Description and Business Overview Table 131. ProMab Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 132. ProMab Human VEGF Antibody Product Table 133. ProMab Recent Developments/Updates Table 134. Creative Biomart Corporation Information Table 135. Creative Biomart Description and Business Overview Table 136. Creative Biomart Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 137. Creative Biomart Human VEGF Antibody Product Table 138. Creative Biomart Recent Developments/Updates Table 139. Enzo Life Sciences Corporation Information Table 140. Enzo Life Sciences Description and Business Overview Table 141. Enzo Life Sciences Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 142. Enzo Life Sciences Human VEGF Antibody Product Table 143. Enzo Life Sciences Recent Developments/Updates Table 144. Bon Opus Biosciences Corporation Information Table 145. Bon Opus Biosciences Description and Business Overview Table 146. Bon Opus Biosciences Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 147. Bon Opus Biosciences Human VEGF Antibody Product Table 148. Bon Opus Biosciences Recent Developments/Updates Table 149. Absolute Antibody Corporation Information Table 150. Absolute Antibody Description and Business Overview Table 151. Absolute Antibody Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 152. Absolute Antibody Human VEGF Antibody Product Table 153. Absolute Antibody Recent Developments/Updates Table 154. US Biological Corporation Information Table 155. US Biological Description and Business Overview Table 156. US Biological Human VEGF Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022) Table 157. US Biological Human VEGF Antibody Product Table 158. US Biological Recent Developments/Updates Table 159. Production Base and Market Concentration Rate of Raw Material Table 160. Key Suppliers of Raw Materials Table 161. Human VEGF Antibody Distributors List Table 162. Human VEGF Antibody Customers List Table 163. Human VEGF Antibody Market Trends Table 164. Human VEGF Antibody Market Drivers Table 165. Human VEGF Antibody Market Challenges Table 166. Human VEGF Antibody Market Restraints Table 167. Global Human VEGF Antibody Sales Forecast by Type (2023-2028) & (Kg) Table 168. Global Human VEGF Antibody Sales Market Share Forecast by Type (2023-2028) Table 169. Global Human VEGF Antibody Revenue Forecast by Type (2023-2028) & (US$ Million) Table 170. Global Human VEGF Antibody Revenue Market Share Forecast by Type (2023-2028) Table 171. Global Human VEGF Antibody Sales Forecast by Application (2023-2028) & (Kg) Table 172. Global Human VEGF Antibody Sales Market Share Forecast by Application (2023-2028) Table 173. Global Human VEGF Antibody Revenue Forecast by Application (2023-2028) & (US$ Million) Table 174. Global Human VEGF Antibody Revenue Market Share Forecast by Application (2023-2028) Table 175. Global Human VEGF Antibody Sales Forecast by Region (2023-2028) & (Kg) Table 176. Global Human VEGF Antibody Sales Market Share Forecast by Region (2023-2028) Table 177. Global Human VEGF Antibody Revenue Forecast by Region (2023-2028) & (US$ Million) Table 178. Global Human VEGF Antibody Revenue Market Share Forecast by Region (2023-2028) Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Human VEGF Antibody Figure 2. Global Human VEGF Antibody Market Share by Type in 2021 & 2028 Figure 3. Rabbit Product Picture Figure 4. Mouse Product Picture Figure 5. Goat Product Picture Figure 6. Others Product Picture Figure 7. Global Human VEGF Antibody Market Share by Application in 2021 & 2028 Figure 8. Laboratory Figure 9. Hospital Figure 10. Others Figure 11. Global Human VEGF Antibody Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Human VEGF Antibody Market Size (2017-2028) & (US$ Million) Figure 13. Global Human VEGF Antibody Sales (2017-2028) & (Kg) Figure 14. Human VEGF Antibody Sales Share by Manufacturers in 2021 Figure 15. Global Human VEGF Antibody Revenue Share by Manufacturers in 2021 Figure 16. The Global 5 and 10 Largest Human VEGF Antibody Players: Market Share by Revenue in 2021 Figure 17. Human VEGF Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 18. Global Human VEGF Antibody Sales Market Share by Region (2017-2022) Figure 19. Global Human VEGF Antibody Sales Market Share by Region in 2021 Figure 20. Global Human VEGF Antibody Revenue Market Share by Region (2017-2022) Figure 21. Global Human VEGF Antibody Revenue Market Share by Region in 2021 Figure 22. U.S. Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Canada Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Germany Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. France Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. U.K. Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Italy Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Russia Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. China Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. Japan Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. South Korea Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. India Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Australia Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Taiwan Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Indonesia Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Thailand Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Malaysia Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Philippines Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Vietnam Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Mexico Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Brazil Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Argentina Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Turkey Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Saudi Arabia Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. UAE Human VEGF Antibody Revenue Growth Rate (2017-2022) & (US$ Million) Figure 46. Sales Market Share of Human VEGF Antibody by Type (2017-2022) Figure 47. Manufacturing Cost Structure of Human VEGF Antibody Figure 48. Manufacturing Process Analysis of Human VEGF Antibody Figure 49. Human VEGF Antibody Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Thermo Fisher MilliporeSigma Santa Cruz Biotechnology Abcam R&D Systems Novus Biologicals Abnova ImmunoStar OriGene LifeSpan Biosciences Sino Biological Bio-Rad BioLegend Rockland Immunochemicals Agrisera Boster ProMab Creative Biomart Enzo Life Sciences Bon Opus Biosciences Absolute Antibody US Biological